4D Molecular Therapeutics (FDMT) FCF Margin Growth (1y) (2021 - 2026)
4D Molecular Therapeutics (FDMT) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | 4D Molecular Therapeutics | 856.62 Mn | 495.28 Mn | - | 30.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.30 Mn |
| Mar 31, 2026 | 33.99 Mn |
| Dec 31, 2025 | 468.12 Mn |
| Sep 30, 2025 | 98.74 Mn |
| Jun 30, 2025 | 31.89 Mn |
| Mar 31, 2025 | -23.57 Mn |
| Dec 31, 2024 | -480.05 Mn |
| Sep 30, 2024 | -103.90 Mn |
| Jun 30, 2024 | -60.29 Mn |
| Mar 31, 2024 | -9.67 Mn |
| Dec 31, 2023 | 12.10 Mn |
| Sep 30, 2023 | 258,255.00 |
| Jun 30, 2023 | 462,240.00 |
| Mar 31, 2023 | -724,603.00 |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | -117,847.00 |
| Jun 30, 2022 | -1.34 Mn |
| Mar 31, 2022 | -168,215.00 |
| Dec 31, 2021 | -2.91 Mn |
| Sep 30, 2021 | -124,426.00 |